Mark Thompson is a top CEO coach and Byron Loflin is Nasdaq's in-house board whisperer. They told Fortune about joining ...
Recent Performance and Context Denali Therapeutics (DNLI) has quietly put together a strong month, with the stock climbing roughly 33% even as its one year return remains negative. This combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback